Efficacy of recombinant human growth hormone in children with juvenile rheumatoid arthritis and growth failure.
about
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.Prognostic factors in juvenile idiopathic arthritis.Growth hormone treatment in children with rheumatic disease, corticosteroid induced growth retardation, and osteopeniaEffects of the use of growth hormone in children and adolescents with juvenile idiopathic arthritis: a systematic review.
P2860
Efficacy of recombinant human growth hormone in children with juvenile rheumatoid arthritis and growth failure.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Efficacy of recombinant human ...... arthritis and growth failure.
@en
Efficacy of recombinant human ...... arthritis and growth failure.
@nl
type
label
Efficacy of recombinant human ...... arthritis and growth failure.
@en
Efficacy of recombinant human ...... arthritis and growth failure.
@nl
prefLabel
Efficacy of recombinant human ...... arthritis and growth failure.
@en
Efficacy of recombinant human ...... arthritis and growth failure.
@nl
P2093
P2860
P1476
Efficacy of recombinant human ...... arthritis and growth failure.
@en
P2093
Al-Ashwal A
Al-Mutair A
P2860
P304
P356
10.1515/JPEM.2000.13.7.899
P577
2000-07-01T00:00:00Z